Tanjore et al. demonstrated the association of neovascular PSMA expression with malignant progression and poor survival after a 10.4-year follow-up of 371 patients with glioblastoma and 52 patients with brain metastatic lung cancer [17]. The gene discussed is FOLH1; the disease is glioblastoma.